Member Info for johnnykipper

The Group was in advanced discussions with the Department of Justice (DOJ) about a possible resolution to
its investigation until recently.
• In December 2018, the company first learned from U.S. Health and Human Services/Office of Inspector
General (HHS/OIG) that the proposed resolution could likely result, in HHS/OIG’s view, in exclusion. This
represented a change in HHS/OIG’s interpretation of its exclusion authority. This change, and HHS/OIG’s
view that the proposed plea by Indivior could result in exclusion from US federal healthcare programs, was
confirmed by HHS/OIG during a meeting in January. These programs are material to the Group’s revenue.
• The Group continued in dialogue with DOJ and HHS/OIG and, at the time of the FY 2018 results, believed
that a resolution was still possible.
• In early April, it became clear that an alternative resolution with DOJ and HHS/OIG would be necessary. DOJ
then did not give the Group sufficient time to negotiate any alternative resolution that would work under
the new HHS/OIG interpretation.

Indivior has indemnification obligations in favor of Reckitt Benckiser (RB). The demerger agreement between Indivior and RB has certain mutual indemnification provisions in respect of any claims and expenses of or incurred by any
company within the Indivior Group or the RB Group arising out of or associated with the Indivior business
prior to the Demerger (whether or not in the ordinary course of business) and in respect of certain tax
liabilities that may arise after, or as part of, the Demerger. Some of these indemnities are unlimited in
terms of amount and duration, and amounts potentially payable by the Indivior Group pursuant to such
indemnity obligations could be significant and could have a material adverse effect on the Indivior Group’s
business, financial condition and/or operating results.

Other points that need to be taken into consideration are as follows: -

1. It is extremely unlikely that they would have to pay a settlement in one go, it would be spread over a number of years.

2. They stated in May that they had been extremely close to a settlement with the DoJ and the only thing that stopped this was issues that came about from others regarding a change in rules relating to future participation in various medical programmes which are basically crucial to Indv continuing. So you would expect that with regards to the proposed settlement at that time they knew exactly how much monies they would have to contribute. This will no doubt have to be increased to satisfy "other" parties to continue accessing the various programmes but the allowance they put aside must be in the ballpark.

https://www.courtlistener.com/docket/14903922/227/united-states-v-indivior-inc/

Eviking's post is an extract of the Notice from October. The DoJ repsonse dosen't make quite so good reading.

Dog of a share, falls nearly 7%., on what news? next to none!

The decision about Braeburn was published on Thursday. We had a day of trading since then where the share price went up.

They briefly discussed the possibility at the sharecast and stated that they were assuming the date would be Nov 2020 but they did not know what impact this would have as nobody really knows what Braeburns plans are at this stage.

RB would also be grateful if you stuck about here. You know more about this share than the rest of us put together

Made the same RNS this time last year.

All over this at these levels

https://www.bbc.co.uk/news/business-50121708

Four companies that settled today.

In Monday's deal, they did not admit guilt. But McKesson Corp, Cardinal Health and AmerisourceBergen Corp agreed to pay $215m, while Teva is paying $20m and will contribute $25m worth of treatment medication.

Later on Monday, Teva also said it had reached an "agreement in principle" for a global settlement, which would see it pay $250m and donate treatment medication worth an estimated $23bn over 10 years.

After todays RNS this looks like a bargain. Should bget to £0.60 from here.

Surprised it has not sunk further.

Cannot see where a turnaround is coming from.

I meant a million pounds worth :-)

Big seller dumped over a million shares at a discounted price.

Billygoat thought you sold up last friday? You back in for one last throw of the dice?

I think many believed at the time that FIL had purchased from Hargreaves Hale?

This was the most up to date list prior to JD purchasing: -

Hargreave Hale Ltd. AS OF 02 NOV 2017
7.93m 7.59%
Artemis Investment Management LLP AS OF 26 JUN 2018
6.01m 5.75%
FIL Investment Advisors (UK) Ltd. AS OF 16 NOV 2018
5.95m 5.70%
Henderson Global Investors Ltd. AS OF 02 NOV 2017
3.66m 3.50%
Merian Global Investors (UK) Ltd. AS OF 22 JUN 2018
3.12m 2.99%
Cavendish Asset Management Ltd. AS OF 31 JAN 2019
2.51m 2.41%
The Independent Investment Trust Plc (Investment Management) AS OF 30 NOV 2017
1.99m 1.90%
AXA Investment Managers UK Ltd. AS OF 31 OCT 2018
617.76k 0.59%
Teviot Partners LLP AS OF 31 DEC 2018
556.69k 0.53%
Schroder Investment Management Ltd. AS OF 30 NOV 2018
220.37k 0.21%

Pokerchips -

The day Tesco reported that loss it closed at 222.7p
Today, just over 3.5 years later it closed at 216.40p

Not really the best comparison to use.

Wise decision onedaywewillbe. Keep your powder dry on this one for as long as possible.